trending Market Intelligence /marketintelligence/en/news-insights/trending/eonKVuloacFYsVWho72qJg2 content esgSubNav
In This List

XTL Biopharmaceuticals announces stock split

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Video

S&P Capital IQ Pro | Powering Your Edge

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Insight Weekly: Labor market struggles; solar demand remains strong; banks' deposit holdings


XTL Biopharmaceuticals announces stock split

XTL Biopharmaceuticals Ltd. announced a stock split that will take effect Feb. 10.

XTL Biopharmaceuticals' depositary share will represent 100 ordinary shares of the company at that date as opposed to 20 ordinary shares previously.

The split will help the company regain compliance with Nasdaq's listing requirements.